Michael Bolinder
Chief Executive Officer presso ACACIA PHARMA GROUP PLC
Profilo
Michael Bolinder is the CEO of Acacia Pharma Group Ltd.
since 2019.
Prior to this, he worked as Head of Marketing & Commercial Strategy at Mallinckrodt Pharmaceuticals Ltd.
from 2013 to 2015.
He completed his undergraduate degree from Florida State University.
Posizioni attive di Michael Bolinder
| Società | Posizione | Inizio |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Chief Executive Officer | 01/08/2019 |
Precedenti posizioni note di Michael Bolinder
| Società | Posizione | Fine |
|---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Sales & Marketing | 01/08/2015 |
Formazione di Michael Bolinder
| Florida State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: OtherHealth Technology Acacia Pharma Group Plc is a holding company, which engages in the development and commercialization of pharmaceutical product. It focuses on the new nausea and vomiting treatments for surgical and cancer patients. The company was founded by Julian Clive Gilbert, Robert William Gristwood, and Andrew Muncey in 2007 and is headquartered in Duxford, the United Kingdom. | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
- Borsa valori
- Insiders
- Michael Bolinder
